Chiara Lago
Trento, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Modeling pediatric low-grade glioma heterogeneity using human forebrain organoids.
Journal: Molecular cancer
Published: October 21, 2025
Patient-derived ependymoma and medulloblastoma tumoroids: generation, biobanking and drug screening.
Patient-derived ependymoma and medulloblastoma tumoroids: generation, biobanking and drug screening.
Journal: Nature protocols
Published: April 17, 2025
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma.
Journal: Acta neuropathologica communications
Published: April 15, 2024
HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.
Journal: Cell death discovery
Published: March 08, 2024
HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.
Journal: bioRxiv : the preprint server for biology
Published: October 31, 2023
Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
Journal: EMBO molecular medicine
Published: June 21, 2023
The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment.
Journal: Cell death & disease
Published: June 13, 2023
Notch1 switches progenitor competence in inducing medulloblastoma.
Journal: Science advances
Published: June 11, 2020
Modeling medulloblastoma in vivo and with human cerebellar organoids.
Journal: Nature communications
Published: October 31, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026